SMAD2 and cervical cancer: A research uncovered that reduced miR-484 expression levels in clinical cervical cancer specimens and cell lines could restore ZEB1 and SMAD2, key transcription factors of epithelial-mesenchymal transition (EMT), inducing CC malignant behavior (45) (Table 3).